US drug prices drop 15% within 18 months of Trump reforms

If Trump-backed drug pricing reforms pass Congress, major pharmaceutical companies will face significant pressure to reduce prices. Leading generic and branded drug manufacturers will likely adjust pricing to comply, driving a measurable decrease in overall drug costs.

Implied probability (Yes)

70%